Omeros Shares Owned By Insiders vs. Total Debt
| 3O8 Stock | EUR 10.09 0.58 5.44% |
For Omeros profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Omeros to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Omeros utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Omeros's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Omeros over time as well as its relative position and ranking within its peers.
Omeros |
Omeros Total Debt vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Omeros's current stock value. Our valuation model uses many indicators to compare Omeros value to that of its competitors to determine the firm's financial worth. Omeros is number one stock in shares owned by insiders category among its peers. It also is the top company in total debt category among its peers making up about 77,819,762 of Total Debt per Shares Owned By Insiders. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omeros' earnings, one of the primary drivers of an investment's value.Omeros Total Debt vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Omeros |
| = | 4.03 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Omeros |
| = | 313.46 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Omeros Total Debt vs Competition
Omeros is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 123.37 Billion. Omeros adds roughly 313.46 Million in total debt claiming only tiny portion of stocks in Biotechnology industry.
Omeros Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Omeros, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Omeros will eventually generate negative long term returns. The profitability progress is the general direction of Omeros' change in net profit over the period of time. It can combine multiple indicators of Omeros, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people.
Omeros Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Omeros. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Omeros position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Omeros' important profitability drivers and their relationship over time.
Use Omeros in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.Omeros Pair Trading
Omeros Pair Trading Analysis
The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.
The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Omeros position
In addition to having Omeros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Omeros Stock
When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:Check out Trending Equities. For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
To fully project Omeros' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Omeros at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Omeros' income statement, its balance sheet, and the statement of cash flows.